Works matching DE "PANCREATIC intraepithelial neoplasia"
Results: 946
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 29, doi. 10.1007/s10555-023-10125-y
- By:
- Publication type:
- Article
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 725, doi. 10.1007/s10555-023-10127-w
- By:
- Publication type:
- Article
Pancreatic cancer pathology viewed in the light of evolution.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 661, doi. 10.1007/s10555-020-09953-z
- By:
- Publication type:
- Article
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 1, p. 245, doi. 10.1007/s10555-020-09952-0
- By:
- Publication type:
- Article
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1.
- Published in:
- Science Immunology, 2023, v. 8, n. 89, p. 1, doi. 10.1126/sciimmunol.adj5097
- By:
- Publication type:
- Article
Cephalic undifferentiated carcinoma with osteoclast-like giant cells arising from the main pancreatic duct: case report and literature review.
- Published in:
- Archive of Clinical Cases, 2019, v. 6, n. 1, p. 6, doi. 10.22551/2019.22.0601.10148
- By:
- Publication type:
- Article
CLINICAL SIGNIFICANCE OF HIGH GRADE AND LOW GRADE PROSTATE INTRAEPITHELIAL NEOPLASIA.
- Published in:
- Medical Perspectives / Medičnì Perspektivi, 2021, v. 26, n. 2, p. 134, doi. 10.26641/2307-0404.2021.2.234640
- By:
- Publication type:
- Article
FOLFIRINOX in adjuvant and metastatic settings for pancreatic cancer in the era of precision oncology.
- Published in:
- Oncolog-Hematolog, 2021, n. 54, p. 32, doi. 10.26416/onhe.5.1.2021.4574
- By:
- Publication type:
- Article
M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 499, doi. 10.3390/vaccines11030499
- By:
- Publication type:
- Article
内镜黏膜下剥离术和挖除术治疗上消化道肿瘤的疗效及安全性分析.
- Published in:
- Progress in Modern Biomedicine, 2019, v. 19, n. 17, p. 3356, doi. 10.13241/j.cnki.pmb.2019.17.033
- By:
- Publication type:
- Article
Recurrent acute pancreatitis in bowel malrotation.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.
- Published in:
- National Science Review, 2022, v. 9, n. 5, p. 1, doi. 10.1093/nsr/nwab212
- By:
- Publication type:
- Article
Importance of atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H).
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2019, v. 36, n. 4, p. 113, doi. 10.5835/jecm.omu.36.04.003
- By:
- Publication type:
- Article
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 6, p. 1, doi. 10.1002/ctm2.1736
- By:
- Publication type:
- Article
Bidirectional crosstalk between cancer cells and cancer‐associated fibroblasts in mixed organoid system elicits transcriptomic characteristics of pancreatic cancer with potential therapeutic vulnerabilities.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 2, p. 1, doi. 10.1002/ctm2.1597
- By:
- Publication type:
- Article
Macrophage‐derived TNF‐enriched tumour microenvironment shapes pancreatic ductal adenocarcinoma into the basal‐like molecular phenotype through upregulating TAp63.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 12, p. 1, doi. 10.1002/ctm2.1520
- By:
- Publication type:
- Article
Hypoxic microenvironment determines the phenotypic plasticity and spatial distribution of cancer‐associated fibroblasts.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1438
- By:
- Publication type:
- Article
A peek at the other side of the coin: Tumor‐suppressor role of microRNAs expressed by pancreatic cancer‐associated fibroblasts.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 8, p. 1, doi. 10.1002/ctm2.1357
- By:
- Publication type:
- Article
An optimized integrin α6‐targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.1002/ctm2.157
- By:
- Publication type:
- Article
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1339302
- By:
- Publication type:
- Article
LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1336251
- By:
- Publication type:
- Article
LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1336251
- By:
- Publication type:
- Article
Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1186101
- By:
- Publication type:
- Article
Pancreatic cancer challenge in 52 Asian countries: age-centric insights and the role of modifiable risk factors (1990-2019).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1271370
- By:
- Publication type:
- Article
Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1218128
- By:
- Publication type:
- Article
Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1244578
- By:
- Publication type:
- Article
Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1236435
- By:
- Publication type:
- Article
UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p/BRCC3.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1133200
- By:
- Publication type:
- Article
Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T<sub>4</sub>, N² disease, positive resection margin, and receiving adjuvant chemotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1109068
- By:
- Publication type:
- Article
Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1156769
- By:
- Publication type:
- Article
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1169586
- By:
- Publication type:
- Article
Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1174577
- By:
- Publication type:
- Article
NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1155831
- By:
- Publication type:
- Article
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1211292
- By:
- Publication type:
- Article
Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1149551
- By:
- Publication type:
- Article
[<sup>18</sup>F]AlF-NOTA-ADH-1: A new PET molecular radiotracer for imaging of N-cadherinpositive tumors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1126721
- By:
- Publication type:
- Article
Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1132424
- By:
- Publication type:
- Article
Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1170513
- By:
- Publication type:
- Article
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1160824
- By:
- Publication type:
- Article
The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.920896
- By:
- Publication type:
- Article
RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1078076
- By:
- Publication type:
- Article
Combined CT and serum CA19-9 for stratifying risk for progression in patients with locally advanced pancreatic cancer receiving intraoperative radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1155555
- By:
- Publication type:
- Article
Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1112576
- By:
- Publication type:
- Article
Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1112104
- By:
- Publication type:
- Article
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1154581
- By:
- Publication type:
- Article
Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1178966
- By:
- Publication type:
- Article
Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1119763
- By:
- Publication type:
- Article
Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1149942
- By:
- Publication type:
- Article
FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1096499
- By:
- Publication type:
- Article